Immutep and Dr Reddy’s enter Exclusive Licensing Agreement for Eftilagimod Alfa
Deal covers commercialisation and development rights outside key regulated markets
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Anuh Pharma receives Certificate of Suitability from EDQM for Sulfadimethoxine
Company shares regulatory milestone and product details
Satya Karm Punia joins Putin’s India visit as part of official business delegation
Indian-origin pharma leader represented Russia in bilateral trade discussions
Senores Pharmaceuticals receives Philippine FDA approval for 10 products
Company expands presence in Southeast Asia with new regulatory clearances
Lupin receives tentative U.S. FDA approval for Siponimod Tablets
Approval covers 0.25 mg, 1 mg and 2 mg strengths for multiple sclerosis treatment
Medley launches Biscal D –Calcium and Vitamin D3 fortified biscuit
Medley expands nutraceutical portfolio with fortified biscuit offering
Lupin signs exclusive licensing agreement with Valorum Biologics for Armlupeg in the U.S.
Companies outline roles in manufacturing, commercialisation and distribution
Granules India reports completion of FDA inspection with zero observations
Granules India outlines the inspection outcome and operational role of its U.S. subsidiary
Urgent reforms to ensure safe medicines: Need of the hour
Dr Suresh Saravdekar, former Assistant Director, Ministry of Medical Education and Health, State of Maharashtra, and Honorary…
India pharma and healthcare funding reaches $38.6 million in November 2025
Early-stage deals account for majority of investment activity